Skip to main content
DRUG logo

DRUG · Bright Minds Biosciences Inc.

$77.29 +2.68 (+3.59%) At close · Jul 21
Market Cap
$740.42M
Shares
9.81M

Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score
69/100
Short interest 9.7% of shares — P88 Days to cover 3.6 — P67 Price vs VWAP +4.7% — P74 Short-volume trend -9.4% — P20 Short interest change +16.5% — P74 Worst FTD 0.12% of shares — P77

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-06-30 952,509 817,654 +134,855 3.60
2026-06-15 817,654 805,672 +11,982 1.34
2026-05-29 805,672 756,484 +49,188 2.88
2026-05-15 756,484 751,049 +5,435 3.68
2026-04-30 751,049 648,636 +102,413 4.34
2026-04-15 648,636 703,646 -55,010 3.54
2026-03-31 703,646 529,485 +174,161 4.56
2026-03-13 529,485 488,136 +41,349 4.02
2026-02-27 488,136 491,033 -2,897 6.64
2026-02-13 491,033 524,789 -33,756 3.87
2026-01-30 524,789 564,277 -39,488 4.37
2026-01-15 564,277 336,924 +227,353 1.56
2025-12-31 336,924 307,407 +29,517 1.68
2025-12-15 307,407 270,495 +36,912 1.97
2025-11-28 270,495 273,186 -2,691 2.07
2025-11-14 273,186 233,622 +39,564 1.32
2025-10-31 233,622 231,038 +2,584 1.39
2025-10-15 231,038 202,787 +28,251 2.05
2025-09-30 202,787 200,442 +2,345 1.97
2025-09-15 200,442 197,860 +2,582 1.91
2025-08-29 197,860 201,534 -3,674 5.17
2025-08-15 201,534 203,749 -2,215 3.27
2025-07-31 203,749 169,044 +34,705 4.90
Showing 1–23 of 23 settlements
Key facts CIK 1827401 CUSIP 10919W405 13F (30d) 3 filings 3 filers Visit website Investor relations